MED - Latest News

Medifast, Inc. (MED), operates in Industrials / Personal Products & Services, trades on NYSE.

Market capitalization stands near $127.2M. Beta to the broader market is 0.70.

The article list below shows the most recent MED headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MED Headlines

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

zacks.com - Aug 12, 2026

MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.

Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?

zacks.com - Aug 7, 2026

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.

MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?

zacks.com - Aug 7, 2026

Medifast stock gains 13. 6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.

Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?

zacks.com - Aug 7, 2026

Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.

Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)

seekingalpha.com - Aug 5, 2026

Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown again in the Q2 report.

How News Affects MED Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MED's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MED news questions

What is the latest MED news headline?
The most recent MED headline (Aug 12, 2026) is "Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the MED news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What MED news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual MED options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.